Education
About Us
Working with TipRanks
Follow Us
Arthur Lee Rosenthal Insider Profile
4 Followers
Arthur Lee Rosenthal, Director at Profound Medical, holds 17.30K shares in Profound Medical (Ticker: TSE:PRN). Most recently, Arthur Lee Rosenthal Bought C$10,800 shares of Profound Medical on Jun 03, 2022 for an estimated value of 97.92K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+1.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Arthur Lee Rosenthal's holdings
Insider Roles
Director
Roles that Arthur Lee Rosenthal holds in companies
Most Profitable Insider Trade
The most profitable trade made by Arthur Lee Rosenthal
Arthur Lee Rosenthal's Trading History
List of latest transactions for each holding click on a transaction to see Arthur Lee Rosenthal's performance on stock
You May Also Like
Arthur Lee Rosenthal insider profile FAQ
What is the percentage of profitable transactions made by Arthur Lee Rosenthal?
The percentage of profitable transactions made by Arthur Lee Rosenthal is 50%.
What is the average return per transaction made by Arthur Lee Rosenthal?
The average return per transaction made by Arthur Lee Rosenthal is 1.50%.
What stocks does Arthur Lee Rosenthal hold?
Arthur Lee Rosenthal holds: TSE:PRN stocks.
What was Arthur Lee Rosenthal’s latest transaction?
Arthur Lee Rosenthal latest transaction was an Informative Buy of C$97.92K.
What was Arthur Lee Rosenthal's most profitable transaction?
Arthur Lee Rosenthal’s most profitable transaction was an Informative Buy of TSE:PRN stock on June 3, 2022. The return on the trade was 51.80%.
What is Arthur Lee Rosenthal's role in Profound Medical?
Arthur Lee Rosenthal's role in Profound Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.